 |
 |
 |
|
Prevalence (15%) and incidence of delta hepatitis in HIV-HBV coinfected patients in the Dat'AIDS (French) cohort
|
|
|
Conclusion: HDV coinfection is common in HIV-HBV coinfected patients in France. Most HDV infections are prevalent infections, but some incident infections occurred during follow-up indicating that HDV transmission is still present in this population. Patients born in Africa or in Eastern Europe, IVDU and HBV-HCV coinfected patients are high-risk populations for HDV infection and should be targeted for systematic screening.
Among HIV-HBV coinfected patients, HDV prevalence rate reached 56.5% in IV drug users (IVDU), 38.2% in patients from Eastern Europe and 42.4% in patients coinfected with HCV.





|
|
|
 |
 |
|
|